TY - JOUR
TI - Vandetanib for medullary thyroid cancer
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2013
ET - 2013/09/02
VL - 36
IS - 5
SP - 174
EP - 179
DO - 10.18773/austprescr.2013.073
LA - eng
UR - https://australianprescriber.tg.org.au/articles/vandetanib-for-medullary-thyroid-cancer.html
KW - Vandetanib
KW - Medullary thyroid carcinoma
KW - Caprelsa
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -